Related Experiment Video
Updated: Dec 19, 2025

A Tactile Automated Passive-Finger Stimulator TAPS
Published on: June 3, 2009
Bayesian Methods in Regulatory Science
1Division of Oncology Biostatistics & Bioinformatics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore MD 21205.
Abstract:
Regulatory science comprises the tools, standards, and approaches that regulators use to assess safety, efficacy, quality, and performance of drugs and medical devices. A major focus of regulatory science is the design and analysis of clinical trials. Clinical trials are an essential part of clinical research programs that aim to improve therapies and reduce the burden of disease. These clinical experiments help us learn about what works clinically and what does not work. The results of clinical trials support therapeutic and policy decisions. When designing clinical trials, investigators make many decisions regarding various aspects of how they will carry out the study, such as the primary objective of the study, primary and secondary endpoints, methods of analysis, sample size, etc. This paper provides a brief review of the clinical development of new treatments and argues for the use of Bayesian methods and decision theory in clinical research.
Insights
Regulatory science uses tools and standards to evaluate drug and device safety and efficacy. This paper advocates for Bayesian methods and decision theory in clinical trial design and analysis for better treatment development.
Area of Science:
- Regulatory science
- Clinical trial design and analysis
- Drug and medical device evaluation
Background:
- Regulatory science provides essential tools and standards for assessing the safety, efficacy, quality, and performance of drugs and medical devices.
- Clinical trials are a cornerstone of clinical research, crucial for improving therapies and understanding treatment effectiveness.
- The design of clinical trials involves critical decisions on objectives, endpoints, analysis methods, and sample size.
Purpose of the Study:
- To review the clinical development process for new treatments.
- To advocate for the integration of Bayesian methods and decision theory in clinical research.
- To enhance the rigor and efficiency of clinical trial design and analysis.
Main Methods:
- Review of clinical development processes.
- Argumentation for Bayesian methods in clinical research.
- Discussion of decision theory applications in trial design.
Main Results:
- Clinical trials are fundamental to therapeutic and policy decisions.
- Current clinical trial design involves numerous critical choices.
- Bayesian methods and decision theory offer potential improvements for clinical research.
Conclusions:
- The adoption of Bayesian methods and decision theory can strengthen clinical trial design and analysis.
- Improved clinical trial methodologies are vital for advancing medical treatments.
- Regulatory science plays a key role in ensuring the safety and efficacy of medical interventions.
More Related Videos
13:04Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
07:05Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Regression Toward the Mean
Statistical Methods for Analyzing Epidemiological Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...